Morphic in the Media
Broadcast
EndoBarrier Data at 2018 American Diabetes Association (ADA) Annual Meeting
Robert EJ Ryder, MD interviewed at 2018 ADA Annual Meeting on latest EndoBarrier data.
Click the title above to watch the video.
Philadelphia CBS Channel 3
New treatment for patients with type 2 diabetes. New FDA studies pending.
Click the title above to watch the video.
West Virginia CBS Channel 5
New treatment for patients with type 2 diabetes. New FDA studies pending.
Click the title above to watch the video.
New York CBS Channel 2
New treatment for patients with type 2 diabetes. New FDA studies pending.
Click the title above to watch the video.
Print Publication
BioWorld
GI Dynamics enrolls first patient in pivotal EndoBarrier trial
Michigan Health Lab
Minimally-Invasive, Innovative Therapy Used for Treating Type 2 Diabetes and Obesity U-M expert discusses an upcoming clinical trial involving a new non-invasive, endoscopic weight-loss procedure called the EndoBarrier®.
Medical Device and Diagnostic Industry (MD+DI)
GI Dynamics continues to turn its story around with UK study.
Everyday Health
The EndoBarrier Device for Type 2 Diabetes: What You Need to Know
Diabetes.co.uk
EndoBarrier – What is the EndoBarrier?
Boston Globe
New Devices to Combat Obesity, from Three Boston-Area Firms
Mass Device
GI Dynamics wins FDA nod for pivotal US EndoBarrier trial
Medscape
Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2 diabetes, after some issues with the device in earlier trials.
Healthcare Global
New EndoBarrier tech looks set to rival traditional gastric bypass surgery.
The Guardian (UK)
The Guardian reports: “Device that helps obese diabetic lose weight ‘should be rolled out across NHS’”
